Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2022

Exploiting synthetic lethality: The next generation

Next generation synthetic lethal target discovery using high-throughput CRISPR technology

Date

09 Sep 2022

Session

Exploiting synthetic lethality: The next generation

Topics

Cancer Biology;  Targeted Therapy;  Molecular Oncology

Tumour Site

Colon and Rectal Cancer

Presenters

Matthew Garnett

Authors

M. Garnett

Author affiliations

  • Wellcome Trust Sanger Institute, CB10 1SA - Cambridge/GB

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Discussion

Presenter: All Speakers

Session: Exploiting synthetic lethality: The next generation

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.